331 – 340 of 715
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Genetically Distinct Subsets within ANCA-Associated Vasculitis
(
- Contribution to journal › Article
-
Mark
How can we predict the risk of relapse in antineutrophil cytoplasmic antibody-associated vasculitis? Comment on the article by Walsh et al Reply
(
- Contribution to journal › Letter
-
Mark
Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Rapid, dynamic changes in glomerular permeability to macromolecules during systemic Angiotensin II (AngII) infusion in rats.
(
- Contribution to journal › Article
-
Mark
Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction
(
- Contribution to journal › Article
-
Mark
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up Study.
(
- Contribution to journal › Article
-
Mark
Increased risk of end-stage renal disease in individuals with coeliac disease
(
- Contribution to journal › Article
-
Mark
Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
(
- Contribution to journal › Article
-
Mark
Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.
(
- Contribution to journal › Article